scispace - formally typeset
J

Janneke Wilschut

Researcher at Erasmus University Rotterdam

Publications -  36
Citations -  1678

Janneke Wilschut is an academic researcher from Erasmus University Rotterdam. The author has contributed to research in topics: Medicine & Colorectal cancer. The author has an hindex of 15, co-authored 26 publications receiving 1590 citations.

Papers
More filters
Journal ArticleDOI

Evaluating Test Strategies for Colorectal Cancer Screening: A Decision Analysis for the U.S. Preventive Services Task Force

TL;DR: Two independent microsimulation modeling groups from the Cancer Intervention and Surveillance Modeling Network (CISNET), funded by the National Cancer Institute, used a comparative modeling approach to compare life-years gained relative to resource use of different strategies for colorectal cancer screening.
Journal ArticleDOI

Screening for colorectal cancer: random comparison of guaiac and immunochemical faecal occult blood testing at different cut-off levels

TL;DR: In conclusion, immunochemical faecal occult blood testing is considerably more effective than gFOBT screening within the range of tested cut-off values and an acceptable trade-off between detection rate and NNscope.
Journal ArticleDOI

Cost-effectiveness analysis of a quantitative immunochemical test for colorectal cancer screening

TL;DR: FIT screening is more cost-effective at a cutoff level of 50 ng/mL than at higher cutoff levels, which is considerably lower than the values used in current practice.
Journal ArticleDOI

Diagnostic Yield Improves With Collection of 2 Samples in Fecal Immunochemical Test Screening Without Affecting Attendance

TL;DR: There is no difference in attendance for subjects offered 1- or 2-sample FIT screening, which allows for the development of efficient FIT Screening strategies that can be adapted for local colonoscopy capacities, rather than varying the cut-off value in a 1-sample strategy.
Journal ArticleDOI

Individualizing colonoscopy screening by sex and race.

TL;DR: The improvements in costs and effects of individualizing CRC screening on a population level were only marginal, and individualized guidelines could contribute to decreasing disparities between blacks and whites.